Titan Pharmaceuticals, Inc.

549300NOUZGB2ZNVJ794

The entity

Status: Active
LEI status: Lapsed - not renewed
Category: Company
Legal form: Corporation (XTIQ)
Jurisdiction: US-DE

Address

Country: United States
Legal address: C/O The Prentice-Hall Corporation System, Inc., 2711 Centerville Road, Suite 40019808 WilmingtonUnited States (US-DE)
Head office: 400 Oyster Point Boulevard, Suite 50594080 South San FranciscoUnited States (US-CA)

Identifier

LEI: 549300NOUZGB2ZNVJ794
Registered: September 12, 2015 at 02:26 AM UTC
Last updated: August 4, 2023 at 04:59 PM UTC
Next renewal: September 29, 2018 at 02:23 PM UTC
Issuer: Bloomberg (5493001KJTIIGC8Y1R12)
Registered with: Division of Corporations, Department of State (RA000602)
Identifier: 2287466
Verified against: Division of Corporations, Department of State (RA000602)
Verified as: 2287466
Corroboration: Confirmed against a public register
GLEIF conformity: Does not meet the standard

Corporate structure

Why no parent is reported

No direct parent reportedNo ultimate parent reported: The accounts are not published

Machine access

REST: https://lei.online/v1/entities/549300NOUZGB2ZNVJ794This record as JSON.
MCP: https://lei.online/mcpThe same data as an MCP tool.

Start a new search